Plant mediated biosynthesis of Mn3O4 nanostructures and their biomedical applications

© 2024 Published by Elsevier Ltd..

Nanomaterials have drawn significant attention for their biomedical and pharmaceutical applications. In the present study, manganese tetra oxide (Mn3O4) nanoparticles were prepared greenly, and their physicochemical properties were studied. Taxus baccata acetone extract was used as a safely novel precursor for reducing and stabilizing nanoparticles. The synthesized nanoparticles were characterized by transmission electron microscopy (TEM), scanning electron microscopy (SEM), energy-dispersive X-ray spectroscopy (EDS), Brunauer-Emmett-Teller (BET), and Barrett-Joyner-Halenda (BJH) and X-ray diffraction (XRD). The cytotoxicity of Mn3O4 (hausmannite) nanostructures was evaluated against murine macrophage cell line J774-A1 and U87 glioblastoma cancer cells for approximately 72 h. Spherical Mn3O4 nanoparticles with tetragonal spinel structures demonstrated minimal toxicity against normal body cells with CC50 around 876.38 μg mL-1. Moreover, Mn3O4 nanoparticles as well as the combination of antimoniate meglumine and Mn3O4 nanoparticles exhibited maximum mortality in Leishmania major. The synthesized nanominerals displayed a significant inhibitory effect against glioblastoma cancer cells at 100 μg mL-1. The selective cytotoxicity of Mn3O4 nanoparticles indicates that these biogenic agents can be employed simultaneously for diagnostic and therapeutic applications in medical applications.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:10

Enthalten in:

Heliyon - 10(2024), 6 vom: 30. März, Seite e27695

Sprache:

Englisch

Beteiligte Personen:

Binjawhar, Dalal N [VerfasserIn]
Al-Enazi, Nouf M [VerfasserIn]
Alsamhary, Khawla [VerfasserIn]
Kha, Mansour [VerfasserIn]

Links:

Volltext

Themen:

Antileishmanial effects
Gene expression
Hausmannite (Mn3O4) nanostructures
Human glioblastoma cell line U87
Journal Article
Taxus baccata

Anmerkungen:

Date Revised 22.03.2024

published: Electronic-eCollection

Citation Status PubMed-not-MEDLINE

doi:

10.1016/j.heliyon.2024.e27695

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM369994612